Wisnu Ananta Kusuma

Dr. Wisnu Ananta Kusuma

IPB University, Bogor, Jawa Barat, Indonesia
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Journal of Bioscience and Bioengineering
Verified
Journal Article
Closed access
BTBadrut Tamam
Badrut Tamam
DSDahrul Syah
Dahrul Syah
MSMaggy Thenawidjaja Suhartono
Maggy Thenawidjaja Suhartono
WKWisnu Ananta Kusuma
Wisnu Ananta Kusuma
STShinjiro Tachibana
Shinjiro Tachibana
HLHanifah Nuryani Lioe
Hanifah Nuryani Lioe

3 August 2022 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
PDF file
LELinda Erlina
Linda Erlina
RPRafika Indah Paramita
Rafika Indah Paramita
WKWisnu Ananta Kusuma
Wisnu Ananta Kusuma
FFFadilah Fadilah
Fadilah Fadilah
ATAryo Tedjo
Aryo Tedjo
AYArry Yanuar
Arry Yanuar
Background: The number of COVID-19 cases continues to grow in Indonesia. This phenomenon motivates researchers to find alternative drugs that function for prevention or treatment. Due to the rich biodiversity of Indonesian medicinal plants, one alternative is to examine the potential of herbal medicines to support COVID therapy. This study aims to identify potential compound candidates in Indonesian herbal using a machine learning and pharmacophore modeling approaches.Methods: We used three classification methods that had different decision-making processes: support vector machine (SVM), multilayer perceptron (MLP), and random forest (RF). For the pharmacophore modeling approach, we performed a structure-based analysis on the 3D structure of the main protease SARS-CoV-2 (3CLPro) and repurposed SARS, MERS, and SARS-CoV-2 drugs identified from the literature as datasets in the ligand-based method. Lastly, we used molecular docking to analyze the interactions between the 3CLpro and 14 hit compounds from the Indonesian Herbal Database (HerbalDB), with lopinavir as a positive control.Results: From the molecular docking analysis, we found six potential compounds that may act as the main proteases of the SARS-CoV-2 inhibitor: hesperidin, kaempferol-3,4'-di-O-methyl ether (Ermanin); myricetin-3-glucoside, peonidin 3-(4’-arabinosylglucoside); quercetin 3-(2G-rhamnosylrutinoside); and rhamnetin 3-mannosyl-(1-2)-alloside.Conclusions: Our layered virtual screening with machine learning and pharmacophore modeling approaches provided a more objective and optimal virtual screening and avoided subjective decision making of the results. Herbal compounds from the screening, i.e. hesperidin, kaempferol-3,4'-di-O-methyl ether (Ermanin); myricetin-3-glucoside, peonidin 3-(4’-arabinosylglucoside); quercetin 3-(2G-rhamnosylrutinoside); and rhamnetin 3-mannosyl-(1-2)-alloside are potential antiviral candidates for SARS-CoV-2.Moringa oleiferaandPsidium guajavathat consist of those compounds, could be an alternative option as COVID-19 herbal preventions.

26 February 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HRHeru Cahya Rustamaji
Heru Cahya Rustamaji
WKWisnu Ananta Kusuma
Wisnu Ananta Kusuma
SNSri Nurdiati
Sri Nurdiati
IBIrmanida Batubara
Irmanida Batubara
Community detection recognizes groups of densely connected nodes across networks, one of the fundamental procedures in network analysis. This research boosts the standard but locally optimized Greedy Modularity algorithm for community detection. We introduce innovative exploration techniques that include a variety of node and community disassembly strategies. These strategies include methods like non-triad creating, feeble, random as well as inadequate embeddedness for nodes, as well as low internal edge density, low triad participation ratio, weak, low conductance as well as random tactics for communities. We present a methodology that showcases the improvement in modularity across the wide variety of real-world and synthetic networks over the standard approaches. A detailed comparison against other well-known community detection algorithms further illustrates the better performance of our improved method. This study not only optimizes the process of community detection but also broadens the scope for a more nuanced and effective network analysis that may pave the way for more insights as to the dynamism and structures of its functioning by effectively addressing and overcoming the limitations that are inherently attached with the existing community detection algorithms.

12 August 2022 in Animals
Verified
Journal Article
Open access
PDF file
FSFajar Sofyantoro
Fajar Sofyantoro
DYDonan Satria Yudha
Donan Satria Yudha
KLKenny Lischer
Kenny Lischer
TNTri Rini Nuringtyas
Tri Rini Nuringtyas
WPWahyu Aristyaning Putri
Wahyu Aristyaning Putri
RSRespati Tri Swasono
Respati Tri Swasono
Snake envenomation is a severe economic and health concern affecting countries worldwide. Snake venom carries a wide variety of small peptides and proteins with various immunological and pharmacological properties. A few key research areas related to snake venom, including its applications in treating cancer and eradicating antibiotic-resistant bacteria, have been gaining significant attention in recent years. The goal of the current study was to analyze the global profile of literature in snake venom research. This study presents a bibliometric review of snake venom-related research documents indexed in the Scopus database between 1933 and 2022. The overall number of documents published on a global scale was 2999, with an average annual production of 34 documents. Brazil produced the highest number of documents (n = 729), followed by the United States (n = 548), Australia (n = 240), and Costa Rica (n = 235). Since 1963, the number of publications has been steadily increasing globally. At a worldwide level, antivenom, proteomics, and transcriptomics are growing hot issues for research in this field. The current research provides a unique overview of snake venom research at global level from 1933 through 2022, and it may be beneficial in guiding future research.

27 October 2022 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
Abdul Halim UmarAbdul Halim Umar
Abdul Halim Umar
DRDiah Ratnadewi
Diah Ratnadewi
Mohamad RafiMohamad Rafi
Mohamad Rafi
YSYohana Caecilia Sulistyaningsih
Yohana Caecilia Sulistyaningsih
HHHamim Hamim
Hamim Hamim
WKWisnu Ananta Kusuma
Wisnu Ananta Kusuma
Curculigo spp. is a herb that is commonly used in Indonesia to treat diabetes mellitus (DM) . The main active components of Curculigo spp. were identified through our previous metabolomic study and online database platform. However, the biological mechanisms underlying Curculigo spp. activity in treating DM remain unclear. Therefore, in this study, a network pharmacology was used to explore the active compounds of Curculigo spp. and their potential molecular mechanisms for treating DM. Oral bioavailability and drug-likeness from the compounds of Curculigo spp. were screened using Lipinski’s rule of five, BBB, HIA + and Caco-2 permeability criteria. A network of compound–target–disease–pathway was then constructed using Cytoscape. The highest degree compounds and targets were then confirmed by molecular docking and molecular dynamics (MD) simulations. The human body can absorb 33 compounds derived from Curculigo spp. In addition, 58 nodes and 62 edges generated a network analysis with the DM target. The highest degree of the compound–target–disease pathway was for orcinol glucoside, AKR1B1, autoimmune diabetes, bile acid and bile salt metabolism. Furthermore, the computational docking method on Curculigo spp. compounds with the highest degree revealed that orcinol glucoside interacted with PTPN1 through a hydrogen bond and resulted in a binding energy of −7.2 kcal mol−1. Through hydrogen bonds, orcinol glucoside in PTPN1 regulates multiple signaling pathways via the adherens junction pathway, which may play a therapeutic role in DM (type 2 diabetes: obesity). In addition, MD simulation confirmed that orcinol glucoside, is suitable for DM treatment by interacting with PTPN1. Communicated by Ramaswamy H. Sarma

18 May 2022 in Applied Network Science
Verified
Journal Article
Open access
PDF file
HRHeru C. Rustamaji
Heru C. Rustamaji
YSYustina S. Suharini
Yustina S. Suharini
APAngga A. Permana
Angga A. Permana
WKWisnu Ananta Kusuma
Wisnu Ananta Kusuma
SNSri Nurdiati
Sri Nurdiati
TDTaufik Djatna
Taufik Djatna
Cancer patients with comorbidities face various life problems, health costs, and quality of life. Therefore, determining comorbid diseases would significantly affect the treatment of cancer patients. Because cancer disease is very complex, we can represent the relationship between cancer and its comorbidities as a network. Furthermore, the network analysis can be employed to determine comorbidities as a community detection problem because the relationship between cancer and its comorbidities forms a community. This study investigates which community detection algorithms are more appropriate to determine the comorbid of cancer. Given different community findings, this study attempted to analyze the modularity generated by the algorithm to decide the significant comorbid diseases. We retrieved lung cancer comorbid data on the basis of text mining manuscripts in PubMed, searched through disease ontologies, and calculated disease similarity. We investigate 20 algorithms using five modularity metrics and 16 fitness function evaluations to determine the significant comorbid diseases. The results show the five best modularity algorithms, namely label propagation, spinglass, Chinese whispers, Louvain, RB Pots. These five algorithms found significant comorbidities: blood vessels, immune system, bone, pancreas, and metabolic disorders, atrial cardiac septal defect, atrial fibrillation respiratory system, interstitial lung, and diabetes mellitus. The fitness function justifies the results of the community algorithm, and the ones that have a significant effect are average internal degree, size, and edges inside. This study contributes to more comprehensive knowledge and management of diseases in the healthcare context.